Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 39: 1811-1814, 1993;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prence, E. M.
Right arrow Articles by Zalewski, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prence, E. M.
Right arrow Articles by Zalewski, I.

Clinical Chemistry, Vol 39, 1811-1814, Copyright © 1993 by American Association for Clinical Chemistry

Unusual thermolability properties of leukocyte beta-hexosaminidase: implications in screening for carriers of Tay-Sachs disease

EM Prence, MR Natowicz and I Zalewski
Division of Medical Genetics, E.K. Shriver Center, Waltham, MA 02254.

Tay-Sachs disease (TSD), an autosomal recessive neurodegenerative condition, is the result of a deficiency of beta-hexosaminidase A (hex A). Heterozygotic individuals are screened by analysis for hex A and hex B activities; the percent of hex A is the critical determinant of carrier vs noncarrier status. Most laboratories use a heat-inactivation assay that exploits the differential thermolability of the isoenzymes. However, we have found a reciprocal relation between the apparent leukocyte hex A activity and the amount of the sample used in the assay; i.e., a significant increase in the percent of hex A activity with decreasing amounts of sample. Three sets of data indicate that this phenomenon was caused by an effect on the hex B isoenzyme and not on hex A. This variation in hex A activity with sample amount was not observed when a hex A-specific substrate was used. This phenomenon was also not seen in assays of leukocytes from carriers for Sandhoff disease, a condition associated with a reduction in the amount of hex B. Finally, when leukocytes from a TSD homozygote, containing almost no hex A, were analyzed, marked increases in the percent of hex A were observed with decreasing sample concentrations. These data indicate that misdiagnoses could result from variations in sample concentrations used for TSD carrier testing and support the view that the leukocyte concentrations used for these assays should be standardized.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
D. C. Martin, B. L. Mark, B. L. Triggs-Raine, and M. R. Natowicz
Evaluation of the Risk for Tay-Sachs Disease in Individuals of French Canadian Ancestry Living in New England
Clin. Chem., March 1, 2007; 53(3): 392 - 398.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
F. Isman, G. E. Palomaki, and M. R. Natowicz
Lysosomal Enzymes in Human Peripheral Blood Mononuclear Cells and Granulocytes
Clin. Chem., March 1, 2005; 51(3): 646 - 649.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
L. F. Perez and J. C. Tutor
Assay of ß-N-acetylhexosaminidase isoenzymes in different biological specimens by means of determination of their activation energies
Clin. Chem., February 1, 1998; 44(2): 226 - 231.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Association for Clinical Chemistry.